Navigation Links
CPhI Pharma Awards Showcase Industry Drivers

FRANKFURT, Germany, October 24, 2013 /PRNewswire/ --

API Corporation, E-Pharma Trento and Camurus- the 2013 winners

The CPhI Pharma Awards 2013 winners were announced live at the awards ceremony- day one at CPhI Worldwide. Honouring outstanding developments from some key industry players, the awards highlighted ever-advancing market innovations, fundamental to driving growth throughout global pharma.


This year the event, which is the foremost opportunity to recognise outstanding achievement amongst industry peers and pharma leaders, had three categories, designed to recognize innovation in formulation, process development, and packaging. A record-breaking 44 entries were received, 13 for formulation, 18 for process development, and 13 for packaging- a total of nine finalists were chosen, three in each of the categories:

Best Innovation in Process Development

The 2013 winner for Best Innovation in Process Development was deservingly won by API Corporation, acknowledging the Company's leading catalytic system for C-H activation. Many drug substances' pharmaceutical activity is exerted by a structural motif called a biaryl unit. Current synthesis, however, requires large amounts of hazardous chemicals. API's technology conceptually addresses this issue as a catalytic system of C-H activation that both drives down costs and provides an environmentally friendly process. Currently, this technology has been applied to the commercial synthesis of angiotensin II receptor blockers.

Best Innovation in Formulation

The CPhI Pharma Award for Best Innovation in Formulation was received with overwhelming reception as Camurus was announced as this year's winner. Camurus was acknowledged for their fluid Injection depot that delivers therapeutic doses over extended periods - adjustable from days to months - from a single injection. Setting the depot aside from other parenteral technologies of its kind, this fluid injection depot is comprised of a lipid-based liquid solution that transforms into a liquid crystal gel matrix in situ on contact with minute quantities of aqueous fluid at the site of injection. The drug becomes effectively encapsulated and is released in a controlled manner. This provides key benefits compared to other associated market products, by reducing the typical complex manufacturing, reconstitution before administration, refrigerated storage or limited compatibility with biomolecules- clearly highlighting these benefits, the technology has already been licensed to drug giant Novartis.

Best Innovation in Packaging

Of the three innovative Packaging finalists, E-Pharma Trento were the winners of the evening, with their strengthened blister pack to package solid pharmaceutical and nutraceutical forms, providing especial use for fragile tablets. Made of three layers (Al - PVC - PA/Al/PVC) that make the capsule packaging more rigid, it allows the user to push-through tablets without damaging them. The award will help the company "push the product," Silvia Boschetti R&D manager at E-Pharma Trento commented. She continued: "E-Pharma Trento's packaging technology offers an alternative that addresses the disadvantages of existing fragile tablet packaging."

Chris Kilbee, Group Director Pharma at UBM Live, extended his congratulations to all the finalists and the evening's winners and commented: "Our Pharma Awards are an exceptional platform, providing the opportunity to highlight innovations within the industry that are set to drive the pharmaceutical marketplace. As an example, one of our winning technologies has already received significant interest by big pharma, so it is with delight that we are able to showcase such leading innovations. We are already looking forward to next year's event where we hope to see yet more industry-driving award entries".

Notes to editors

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, China, India, Japan, Southeast Asia, Russia and South America co-located with ICSE for contract services, P-MEC for machinery, equipment & technology, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at and hosts a global community with news and analysis at

For more information visit:

The UBM Live annual schedule of Pharmaceutical events also includes CPhI Worldwide, ICSE, P-MEC Europe and InnoPack (22-24 October, 2013 at Messe Frankfurt, Germany); CPhI and P-MEC India (3-5 December, 2013 at the Bombay Exhibition Centre in Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan (9-11 April, 2014 in Tokyo); CPhI Russia and IPhEB (16-17 April, 2014 in St Petersburg, Russia); CPhI, P-MEC and Innopack South East Asia (20-22 May, 2014 in Jakarta, Indonesia); CPhI Istanbul (4-6 June, 2014, Turkey) and CPhI, Hi and Fi, ICSE, P-MEC, BioPh and LabWorld China (26-28 June, 2014 at SNIEC, Shanghai, China).

About UBM Live

UBM Live connects people and creates opportunities for companies across five continents to develop new business, meet customers, launch new products, promote their brands, and expand their market. Through premier brands such as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM Live exhibitions, conferences, awards programs, publications, Websites, and training and certification programs are an integral part of the marketing plans of companies across more than 20 industry sectors.

For media enquiries, please contact:
Alex Heeley or Tristan Jervis    
De Facto Communications
T: +44-(0)207-203-6745 / 6740
E: /

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Increasing Affluence and Legislative Reforms are Transforming Polands Pharmaceutical Market, Which Holds Strategic Importance for Multinational Companies
2. Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2a Cellulite Study of Collegenase Clostridium Histolyticum
3. Avanir Pharmaceuticals to Host Investor Day on October 29, 2013
4. CoLucid Pharmaceuticals and ILDONG Pharmaceutical Enter into a Distribution and Supply Agreement for Lasmiditan, a Novel Agent for Acute Migraine
5. Pharmacy Technician Certification Board Names Linda Henson and Rico Powell as 2013 PTCB CPhT of the Year Finalists
6. Mission Pharmacal Launches Aquoral Oral Spray for Dry Mouth
7. Jazz Pharmaceuticals to Report Third Quarter 2013 Financial Results on November 5, 2013
8. Pharmacy Technician Certification Board Names Master Sergeant Jessica Hughes the 2013 PTCB CPhT of the Year
9. HOPA Introduces Scope Of Hematology/Oncology Pharmacy Practice
10. State Senator Mae Beavers Joins Local Leaders, Retailers, Pharmacists To Launch Anti-Smurfing Public Awareness Campaign
11. Norwich Pharmaceuticals is now Norwich Pharma Services
Post Your Comments:
(Date:10/9/2015)... DIEGO , Oct. 9, 2015 Ansun ... (Infectious Disease Society of America ) regarding the compassionate ... transplant patient on a respirator who was co-infected with ... a five-day course of therapy, O 2 requirement ... the patient was able to go off the respirator ...
(Date:10/8/2015)... October 9, 2015 ® ... diagnostic colonoscopy. The NOCT study also assessed the ... --> ® ) in adult patients ... study also assessed the compliance, safety, patient acceptability ... today announced positive top line results for its ...
(Date:10/8/2015)... PITTSBURGH , Oct. 8, 2015 /PRNewswire/ ... pharmaceutical company, will host a conference call and webcast ... ET to review the value to be created for ... TASE) through Mylan,s offer to acquire the company. During ... outlines the compelling proposition for Perrigo shareholders. Mylan,s offer ...
Breaking Medicine Technology:
... IDEV Technologies, Inc. (IDEV) today announced the firm ... Australia,s regulatory agency for medical drugs and devices, for ... and peripheral procedures. "We are pleased to ... SUPERA VERITAS in the Australian market later this year," ...
... 28, 2011 Onyx Pharmaceuticals, Inc. (Nasdaq: ... evaluating carfilzomib, a selective, next-generation proteasome inhibitor, at the ... Paris, France. "The data we are ... an important new treatment option for patients with multiple ...
Cached Medicine Technology:
(Date:10/9/2015)... ... 09, 2015 , ... A new health tool that helps identify if a ... ( ) – just in time for the cold and flu season, which ... for many in the U.S., the real start of cold/flu season is the start ...
(Date:10/9/2015)... ... October 09, 2015 , ... Dentist in Huntington Beach ... system that uses clear, plastic aligners. This alternative to braces has become wildly ... allow patients to complete treatment in privacy. Additionally, Invisalign aligners are removable, so ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... The Asthma ... the US Centers for Disease Control and Prevention (CDC) to improve the knowledge and ... that AAFA has been awarded a project by the CDC and allows AAFA to ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... individuals from all walks of life to save money on the high cost ... $25 per month per medication, individuals and families can receive their medications delivered ...
(Date:10/9/2015)... ... October 09, 2015 , ... Ryan Fox, ... largest recreational dispensaries in Colorado, says the latest figures on the state’s sales ... maturing into a legitimate industry. , Last month, according to the ...
Breaking Medicine News(10 mins):
... ... Integration project team including Drummond Group Inc., the trusted interoperability test lab, to conduct a ... project and leading the testing efforts with strong support from the project stakeholders. ... Austin, TX (PRWEB) December 7, ...
... ... medical research. , ... AZ (PRWEB) December 7, 2009 -- is doing its part to help find a ... Cure Catheters to its list of nearly 45,000 products., , ,Cure Medical is a forward-thinking ...
... , NEW ORLEANS, Dec. 7 ... Ruth Pettengell, M.D. of St. George,s Hospital, University of London during ... Meeting updated results from the pivotal phase III EXTEND (PIX 301) ... or refractory, aggressive non-Hodgkin,s lymphoma ("NHL") patients who have failed ...
... , OAK BROOK, Ill., Dec. ... academic medical center (AMC) members for their achievements in ... 10 organizations are noted for modeling best practices in ... ) , The winners were determined using 2008 ...
... the loss of a key segment of DNA can lead to ... this kind of genetic alteration can cause obesity. The results are ... Dr Sadaf Farooqi from the University of Cambridge and Dr Matt ... with severe obesity. The team scanned each child,s entire genome ...
... Dec. 6 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) ... 003-A1 study, known as the 003 trial, demonstrating that carfilzomib ... patients. These data were presented today at the ASH/ASCO Joint ... of Hematology (ASH) in New Orleans. Enrollment in this trial ...
Cached Medicine News:
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: